Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
Titel:
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
Auteur:
Finn, Richard S Ryoo, Baek-Yeol Hsu, Chih-Hung Li, Daneng Burgoyne, Adam M Cotter, Christopher Badhrinarayanan, Shreya Wang, Yulei Yin, Anqi Edubilli, Tirupathi Rao Mahrus, Sami Secrest, Matthew H Shemesh, Colby S Yu, Nancy Hack, Stephen P Cha, Edward Gane, Ed
Verschenen in:
Lancet oncology
Paginering:
Jaargang 26 () nr. 2 pagina's 214-226
Jaar:
2025
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC 4.0 license